Merck & Co Inc
Change company Symbol lookup
Select an option...
MRK Merck & Co Inc
SCHW-J Charles Schwab Corp
BIOT Biotech Acquisition Co
MICR Micron Solutions Inc
WSBF Waterstone Financial Inc
MBRX Moleculin Biotech Inc
STRNY Severn Trent PLC
BRSP Brightspire Capital Inc
DBX Dropbox Inc
EESH Eestech Inc
Go

Health Care : Pharmaceuticals | Large Cap Blend
Company profile

Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all livestock and companion animal species.

Closing Price
$86.12
Day's Change
-0.52 (-0.60%)
Bid
--
Ask
--
B/A Size
--
Day's High
87.62
Day's Low
86.10
Volume
(Average)
Volume:
9,035,613

10-day average volume:
8,538,510
9,035,613

MRK's position in the Pharmaceuticals industry

Industry PeersMRKLLYPFEZTSELAN

Summary

Company ProfileMerck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through...
Eli Lilly and Company is engaged in a drug manufacturing business. The Company discovers, develops, manufactures, and markets products in the human pharmaceutical products segment. Its diabetes...
Go to LLY summary
Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products...
Go to PFE summary
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health...
Go to ZTS summary
Elanco Animal Health Incorporated is an animal health company. The Company is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves...
Go to ELAN summary
52-Week Change

VS. INDUSTRY
5.80%
40.84%
1.93%
-24.42%
-61.33%
Market Cap

VS. INDUSTRY
$218.3B
$292.2B
$246.0B
$69.6B
$6.0B
Beta

VS. INDUSTRY
0.3
0.4
0.7
0.8
0.9
Dividend Yield

VS. INDUSTRY
3.20%
1.27%
3.65%
0.87%
--
P/E (TTM, GAAP)

VS. INDUSTRY
13.14x
49.07x
8.45x
33.72x
--
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$57.2B
$29.1B
$101.1B
$8.0B
$4.6B
Profit Margin

VS. INDUSTRY
29.13%
19.58%
29.44%
26.12%
-3.77%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
28.17%
18.88%
27.43%
20.99%
--
Revenue Growth (TTM)

VS. INDUSTRY
30.21%
8.77%
83.48%
7.87%
2.10%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.